Zhonghua nei ke za zhi · 2014
[Evaluation of serum creatinine level in amyotrophic lateral sclerosis patients].
Сравнительное исследованиеАннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ren Yuting, Zhu Wenjia, Cui Fang, Yang Fei, Huang Xusheng
Аннотация
OBJECTIVE: To investigate the serum creatinine (SCr) level in patients with sporadic amyotrophic lateral sclerosis (sALS) and to explore the relationship between the SCr level and the clinical characteristics.
METHODS: A total of 80 patients with sALS, 80 patients with multiple system atrophy (MSA) and 80 patients with tension-type headache (TTH) were enrolled in the study. The SCr levels were compared among the three groups. The association between the SCr level and the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R), the forced vital capacity (FVC) percentage of predicted (FVC%pred), the site of symptom onset, the duration of disease and the rate of disease progression was evaluated in the sALS group.
RESULTS: The SCr level was significantly decreased in the sALS group than the other two groups [(60.86 ± 16.80) µmol/L vs (70.05 ± 12.79) µmol/L and (66.97 ± 14.14) µmol/L, P < 0.01].In the sALS group, the SCr level was positively correlated with the ALSFRS-R (r = 0.315, P = 0.005), while no correlation was found between the SCr level and the FVC%pred, the site of symptom onset, the duration of disease and the rate of disease progression (all P > 0.05).
CONCLUSION: The SCr level is an important biochemical index in the patients with sALS and might play an important role in monitoring the disease progression.
METHODS: A total of 80 patients with sALS, 80 patients with multiple system atrophy (MSA) and 80 patients with tension-type headache (TTH) were enrolled in the study. The SCr levels were compared among the three groups. The association between the SCr level and the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R), the forced vital capacity (FVC) percentage of predicted (FVC%pred), the site of symptom onset, the duration of disease and the rate of disease progression was evaluated in the sALS group.
RESULTS: The SCr level was significantly decreased in the sALS group than the other two groups [(60.86 ± 16.80) µmol/L vs (70.05 ± 12.79) µmol/L and (66.97 ± 14.14) µmol/L, P < 0.01].In the sALS group, the SCr level was positively correlated with the ALSFRS-R (r = 0.315, P = 0.005), while no correlation was found between the SCr level and the FVC%pred, the site of symptom onset, the duration of disease and the rate of disease progression (all P > 0.05).
CONCLUSION: The SCr level is an important biochemical index in the patients with sALS and might play an important role in monitoring the disease progression.